nodes	percent_of_prediction	percent_of_DWPC	metapath
Alitretinoin—ABCB1—Tacrolimus—atopic dermatitis	0.0621	0.193	CbGbCtD
Alitretinoin—CYP1A2—Diphenhydramine—atopic dermatitis	0.052	0.162	CbGbCtD
Alitretinoin—ABCB1—Loratadine—atopic dermatitis	0.0454	0.142	CbGbCtD
Alitretinoin—ABCB1—Methylprednisolone—atopic dermatitis	0.0416	0.129	CbGbCtD
Alitretinoin—ABCB1—Betamethasone—atopic dermatitis	0.027	0.0842	CbGbCtD
Alitretinoin—ABCB1—Prednisolone—atopic dermatitis	0.0267	0.0831	CbGbCtD
Alitretinoin—ABCB1—Hydrocortisone—atopic dermatitis	0.0253	0.0788	CbGbCtD
Alitretinoin—ABCB1—Prednisone—atopic dermatitis	0.0252	0.0785	CbGbCtD
Alitretinoin—CRABP2—skin epidermis—atopic dermatitis	0.0179	0.233	CbGeAlD
Alitretinoin—ABCB1—Dexamethasone—atopic dermatitis	0.0157	0.049	CbGbCtD
Alitretinoin—CRABP1—neck—atopic dermatitis	0.00946	0.123	CbGeAlD
Alitretinoin—RXRG—neck—atopic dermatitis	0.00748	0.0975	CbGeAlD
Alitretinoin—CRABP1—skin of body—atopic dermatitis	0.00612	0.0799	CbGeAlD
Alitretinoin—CRABP2—skin of body—atopic dermatitis	0.00554	0.0722	CbGeAlD
Alitretinoin—RARG—skin of body—atopic dermatitis	0.00404	0.0527	CbGeAlD
Alitretinoin—CRABP1—head—atopic dermatitis	0.00399	0.0521	CbGeAlD
Alitretinoin—CRABP2—head—atopic dermatitis	0.00361	0.0471	CbGeAlD
Alitretinoin—RXRA—head—atopic dermatitis	0.0036	0.0469	CbGeAlD
Alitretinoin—RARB—head—atopic dermatitis	0.00323	0.0421	CbGeAlD
Alitretinoin—RXRG—head—atopic dermatitis	0.00316	0.0412	CbGeAlD
Alitretinoin—RXRB—head—atopic dermatitis	0.00297	0.0387	CbGeAlD
Alitretinoin—RARG—head—atopic dermatitis	0.00264	0.0344	CbGeAlD
Alitretinoin—RARA—head—atopic dermatitis	0.00248	0.0323	CbGeAlD
Alitretinoin—RARG—RXR and RAR heterodimerization with other nuclear receptor—PPARA—atopic dermatitis	0.00163	0.0291	CbGpPWpGaD
Alitretinoin—RXRG—RXR and RAR heterodimerization with other nuclear receptor—PPARA—atopic dermatitis	0.00149	0.0266	CbGpPWpGaD
Alitretinoin—RARB—RXR and RAR heterodimerization with other nuclear receptor—PPARA—atopic dermatitis	0.00147	0.0261	CbGpPWpGaD
Alitretinoin—RXRB—RXR and RAR heterodimerization with other nuclear receptor—PPARA—atopic dermatitis	0.00141	0.025	CbGpPWpGaD
Alitretinoin—RARA—RXR and RAR heterodimerization with other nuclear receptor—PPARA—atopic dermatitis	0.00141	0.025	CbGpPWpGaD
Alitretinoin—RARG—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	0.00132	0.0235	CbGpPWpGaD
Alitretinoin—RARG—Nuclear Receptors—PPARA—atopic dermatitis	0.00121	0.0215	CbGpPWpGaD
Alitretinoin—RARB—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	0.00118	0.021	CbGpPWpGaD
Alitretinoin—RARA—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	0.00113	0.0202	CbGpPWpGaD
Alitretinoin—RXRG—Nuclear Receptors—PPARA—atopic dermatitis	0.0011	0.0196	CbGpPWpGaD
Alitretinoin—RARB—Nuclear Receptors—PPARA—atopic dermatitis	0.00108	0.0193	CbGpPWpGaD
Alitretinoin—RXRB—Nuclear Receptors—PPARA—atopic dermatitis	0.00104	0.0185	CbGpPWpGaD
Alitretinoin—RARA—Nuclear Receptors—PPARA—atopic dermatitis	0.00104	0.0185	CbGpPWpGaD
Alitretinoin—RARG—Nuclear Receptor transcription pathway—PPARA—atopic dermatitis	0.000953	0.017	CbGpPWpGaD
Alitretinoin—RXRG—Adipogenesis—STAT6—atopic dermatitis	0.000906	0.0161	CbGpPWpGaD
Alitretinoin—RXRG—Nuclear Receptor transcription pathway—PPARA—atopic dermatitis	0.000872	0.0155	CbGpPWpGaD
Alitretinoin—RARB—Nuclear Receptor transcription pathway—PPARA—atopic dermatitis	0.000855	0.0152	CbGpPWpGaD
Alitretinoin—RARA—Adipogenesis—STAT6—atopic dermatitis	0.000852	0.0152	CbGpPWpGaD
Alitretinoin—RXRB—Nuclear Receptor transcription pathway—PPARA—atopic dermatitis	0.00082	0.0146	CbGpPWpGaD
Alitretinoin—RARA—Nuclear Receptor transcription pathway—PPARA—atopic dermatitis	0.00082	0.0146	CbGpPWpGaD
Alitretinoin—RARG—Retinoic acid receptors-mediated signaling—MAPK8—atopic dermatitis	0.000809	0.0144	CbGpPWpGaD
Alitretinoin—RXRA—REV-ERBA represses gene expression—PPARA—atopic dermatitis	0.000781	0.0139	CbGpPWpGaD
Alitretinoin—RXRA—RORA activates circadian gene expression—PPARA—atopic dermatitis	0.000756	0.0134	CbGpPWpGaD
Alitretinoin—RXRG—Retinoic acid receptors-mediated signaling—MAPK8—atopic dermatitis	0.00074	0.0132	CbGpPWpGaD
Alitretinoin—RXRA—PPAR Alpha Pathway—PPARA—atopic dermatitis	0.000733	0.013	CbGpPWpGaD
Alitretinoin—RXRA—RXR and RAR heterodimerization with other nuclear receptor—PPARA—atopic dermatitis	0.000733	0.013	CbGpPWpGaD
Alitretinoin—RARB—Retinoic acid receptors-mediated signaling—MAPK8—atopic dermatitis	0.000725	0.0129	CbGpPWpGaD
Alitretinoin—RARG—RXR and RAR heterodimerization with other nuclear receptor—TNF—atopic dermatitis	0.000717	0.0128	CbGpPWpGaD
Alitretinoin—RXRB—Retinoic acid receptors-mediated signaling—MAPK8—atopic dermatitis	0.000695	0.0124	CbGpPWpGaD
Alitretinoin—RARA—Retinoic acid receptors-mediated signaling—MAPK8—atopic dermatitis	0.000695	0.0124	CbGpPWpGaD
Alitretinoin—RXRA—YAP1- and WWTR1 (TAZ)-stimulated gene expression—PPARA—atopic dermatitis	0.000671	0.0119	CbGpPWpGaD
Alitretinoin—RXRG—RXR and RAR heterodimerization with other nuclear receptor—TNF—atopic dermatitis	0.000656	0.0117	CbGpPWpGaD
Alitretinoin—RARB—RXR and RAR heterodimerization with other nuclear receptor—TNF—atopic dermatitis	0.000644	0.0114	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	0.000632	0.0112	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	0.000632	0.0112	CbGpPWpGaD
Alitretinoin—RARA—RXR and RAR heterodimerization with other nuclear receptor—TNF—atopic dermatitis	0.000617	0.011	CbGpPWpGaD
Alitretinoin—RXRB—RXR and RAR heterodimerization with other nuclear receptor—TNF—atopic dermatitis	0.000617	0.011	CbGpPWpGaD
Alitretinoin—RXRA—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PPARA—atopic dermatitis	0.000552	0.00983	CbGpPWpGaD
Alitretinoin—RXRA—Nuclear Receptors—PPARA—atopic dermatitis	0.000541	0.00962	CbGpPWpGaD
Alitretinoin—RXRA—Activation of gene expression by SREBF (SREBP)—PPARA—atopic dermatitis	0.000519	0.00923	CbGpPWpGaD
Alitretinoin—CRABP1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARA—atopic dermatitis	0.000515	0.00916	CbGpPWpGaD
Alitretinoin—CRABP2—Fatty acid, triacylglycerol, and ketone body metabolism—PPARA—atopic dermatitis	0.000515	0.00916	CbGpPWpGaD
Alitretinoin—RXRA—Transcriptional activation of mitochondrial biogenesis—PPARA—atopic dermatitis	0.000472	0.0084	CbGpPWpGaD
Alitretinoin—ABCB1—head—atopic dermatitis	0.000471	0.00614	CbGeAlD
Alitretinoin—RXRG—Regulation of Androgen receptor activity—MAPK8—atopic dermatitis	0.000469	0.00835	CbGpPWpGaD
Alitretinoin—RXRA—Transcription factor regulation in adipogenesis—MAPK8—atopic dermatitis	0.000464	0.00826	CbGpPWpGaD
Alitretinoin—RXRA—Adipogenesis—STAT6—atopic dermatitis	0.000444	0.0079	CbGpPWpGaD
Alitretinoin—RXRB—Regulation of Androgen receptor activity—MAPK8—atopic dermatitis	0.000441	0.00785	CbGpPWpGaD
Alitretinoin—RXRA—Nuclear Receptor transcription pathway—PPARA—atopic dermatitis	0.000427	0.0076	CbGpPWpGaD
Alitretinoin—RXRA—Regulation of cholesterol biosynthesis by SREBP (SREBF)—PPARA—atopic dermatitis	0.000414	0.00737	CbGpPWpGaD
Alitretinoin—RXRG—Adipogenesis—PPARA—atopic dermatitis	0.000413	0.00734	CbGpPWpGaD
Alitretinoin—RXRA—Mitochondrial biogenesis—PPARA—atopic dermatitis	0.000408	0.00726	CbGpPWpGaD
Alitretinoin—CYP1A2—Estrogen Receptor Pathway—PPARA—atopic dermatitis	0.000407	0.00724	CbGpPWpGaD
Alitretinoin—RXRA—Circadian Clock—PPARA—atopic dermatitis	0.000402	0.00716	CbGpPWpGaD
Alitretinoin—RARA—Adipogenesis—PPARA—atopic dermatitis	0.000388	0.0069	CbGpPWpGaD
Alitretinoin—RXRA—Transcription factor regulation in adipogenesis—TNF—atopic dermatitis	0.000368	0.00654	CbGpPWpGaD
Alitretinoin—RXRA—Retinoic acid receptors-mediated signaling—MAPK8—atopic dermatitis	0.000362	0.00645	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—BDNF—atopic dermatitis	0.000359	0.00639	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—BDNF—atopic dermatitis	0.000344	0.00613	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	0.000332	0.0059	CbGpPWpGaD
Alitretinoin—RXRA—RXR and RAR heterodimerization with other nuclear receptor—TNF—atopic dermatitis	0.000322	0.00572	CbGpPWpGaD
Alitretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—PPARA—atopic dermatitis	0.000307	0.00547	CbGpPWpGaD
Alitretinoin—RXRA—Transcription factor regulation in adipogenesis—IL6—atopic dermatitis	0.000297	0.00528	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—GLB1—atopic dermatitis	0.000281	0.005	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—GLB1—atopic dermatitis	0.000281	0.005	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—ADSL—atopic dermatitis	0.00027	0.0048	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—ADSL—atopic dermatitis	0.00027	0.0048	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	0.000263	0.00468	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—FOXP3—atopic dermatitis	0.000259	0.00461	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	0.000252	0.00449	CbGpPWpGaD
Alitretinoin—RXRA—Orphan transporters—PPARA—atopic dermatitis	0.000242	0.0043	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	0.000237	0.00422	CbGpPWpGaD
Alitretinoin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	0.000236	0.0042	CbGpPWpGaD
Alitretinoin—RXRA—PPARA activates gene expression—PPARA—atopic dermatitis	0.000231	0.00411	CbGpPWpGaD
Alitretinoin—RXRA—Regulation of Androgen receptor activity—MAPK8—atopic dermatitis	0.00023	0.00409	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	0.000227	0.00405	CbGpPWpGaD
Alitretinoin—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARA—atopic dermatitis	0.000226	0.00402	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—IL13—atopic dermatitis	0.000222	0.00395	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	0.000205	0.00365	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	0.000205	0.00365	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—IL17A—atopic dermatitis	0.000204	0.00363	CbGpPWpGaD
Alitretinoin—RXRA—Adipogenesis—PPARA—atopic dermatitis	0.000202	0.0036	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	0.000191	0.0034	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—IL5—atopic dermatitis	0.00019	0.00338	CbGpPWpGaD
Alitretinoin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	0.000189	0.00335	CbGpPWpGaD
Alitretinoin—RXRA—Organelle biogenesis and maintenance—PPARA—atopic dermatitis	0.000185	0.0033	CbGpPWpGaD
Alitretinoin—RXRG—Adipogenesis—TNF—atopic dermatitis	0.000181	0.00322	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—BDNF—atopic dermatitis	0.00018	0.00319	CbGpPWpGaD
Alitretinoin—RARA—Adipogenesis—TNF—atopic dermatitis	0.00017	0.00303	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	0.000165	0.00293	CbGpPWpGaD
Alitretinoin—RARG—Generic Transcription Pathway—PPARA—atopic dermatitis	0.000165	0.00293	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	0.000158	0.00281	CbGpPWpGaD
Alitretinoin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—PPARA—atopic dermatitis	0.000156	0.00277	CbGpPWpGaD
Alitretinoin—RXRG—Generic Transcription Pathway—PPARA—atopic dermatitis	0.000151	0.00268	CbGpPWpGaD
Alitretinoin—RARB—Generic Transcription Pathway—PPARA—atopic dermatitis	0.000148	0.00263	CbGpPWpGaD
Alitretinoin—RXRG—Adipogenesis—IL6—atopic dermatitis	0.000146	0.0026	CbGpPWpGaD
Alitretinoin—RXRB—Generic Transcription Pathway—PPARA—atopic dermatitis	0.000142	0.00252	CbGpPWpGaD
Alitretinoin—RARA—Generic Transcription Pathway—PPARA—atopic dermatitis	0.000142	0.00252	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—IL10—atopic dermatitis	0.000139	0.00247	CbGpPWpGaD
Alitretinoin—RARA—Adipogenesis—IL6—atopic dermatitis	0.000137	0.00244	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—IL4—atopic dermatitis	0.000135	0.0024	CbGpPWpGaD
Alitretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—TNF—atopic dermatitis	0.000135	0.0024	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	0.000133	0.00236	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	0.000131	0.00234	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	0.000131	0.00232	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	0.000125	0.00223	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	0.000122	0.00217	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	0.000119	0.00211	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—atopic dermatitis	0.0001	0.00179	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—CASP8—atopic dermatitis	9.6e-05	0.00171	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—PPARA—atopic dermatitis	9.13e-05	0.00162	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—PPARA—atopic dermatitis	9.13e-05	0.00162	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—atopic dermatitis	8.96e-05	0.00159	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—atopic dermatitis	8.92e-05	0.00159	CbGpPWpGaD
Alitretinoin—RXRA—Adipogenesis—TNF—atopic dermatitis	8.87e-05	0.00158	CbGpPWpGaD
Alitretinoin—Shock—Prednisolone—atopic dermatitis	8.6e-05	0.000157	CcSEcCtD
Alitretinoin—Cough—Triamcinolone—atopic dermatitis	8.6e-05	0.000157	CcSEcCtD
Alitretinoin—Headache—Tacrolimus—atopic dermatitis	8.57e-05	0.000157	CcSEcCtD
Alitretinoin—Oedema—Hydrocortisone—atopic dermatitis	8.54e-05	0.000156	CcSEcCtD
Alitretinoin—Anaphylactic shock—Hydrocortisone—atopic dermatitis	8.54e-05	0.000156	CcSEcCtD
Alitretinoin—Convulsion—Triamcinolone—atopic dermatitis	8.53e-05	0.000156	CcSEcCtD
Alitretinoin—Tachycardia—Prednisolone—atopic dermatitis	8.53e-05	0.000156	CcSEcCtD
Alitretinoin—Convulsion—Methylprednisolone—atopic dermatitis	8.52e-05	0.000156	CcSEcCtD
Alitretinoin—RXRA—Metabolism—GLB1—atopic dermatitis	8.51e-05	0.00151	CbGpPWpGaD
Alitretinoin—Hypertension—Triamcinolone—atopic dermatitis	8.5e-05	0.000156	CcSEcCtD
Alitretinoin—Hypertension—Methylprednisolone—atopic dermatitis	8.48e-05	0.000155	CcSEcCtD
Alitretinoin—Infection—Hydrocortisone—atopic dermatitis	8.48e-05	0.000155	CcSEcCtD
Alitretinoin—Hyperhidrosis—Prednisolone—atopic dermatitis	8.45e-05	0.000155	CcSEcCtD
Alitretinoin—Shock—Hydrocortisone—atopic dermatitis	8.4e-05	0.000154	CcSEcCtD
Alitretinoin—Myalgia—Triamcinolone—atopic dermatitis	8.39e-05	0.000154	CcSEcCtD
Alitretinoin—Nervous system disorder—Hydrocortisone—atopic dermatitis	8.37e-05	0.000153	CcSEcCtD
Alitretinoin—Myalgia—Methylprednisolone—atopic dermatitis	8.37e-05	0.000153	CcSEcCtD
Alitretinoin—Arthralgia—Methylprednisolone—atopic dermatitis	8.37e-05	0.000153	CcSEcCtD
Alitretinoin—Eye disorder—Prednisone—atopic dermatitis	8.36e-05	0.000153	CcSEcCtD
Alitretinoin—Anxiety—Methylprednisolone—atopic dermatitis	8.34e-05	0.000153	CcSEcCtD
Alitretinoin—Tachycardia—Hydrocortisone—atopic dermatitis	8.33e-05	0.000153	CcSEcCtD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	8.31e-05	0.000152	CcSEcCtD
Alitretinoin—Flushing—Prednisone—atopic dermatitis	8.3e-05	0.000152	CcSEcCtD
Alitretinoin—Skin disorder—Hydrocortisone—atopic dermatitis	8.29e-05	0.000152	CcSEcCtD
Alitretinoin—Ill-defined disorder—Dexamethasone—atopic dermatitis	8.29e-05	0.000152	CcSEcCtD
Alitretinoin—Ill-defined disorder—Betamethasone—atopic dermatitis	8.29e-05	0.000152	CcSEcCtD
Alitretinoin—Discomfort—Triamcinolone—atopic dermatitis	8.29e-05	0.000152	CcSEcCtD
Alitretinoin—Discomfort—Methylprednisolone—atopic dermatitis	8.27e-05	0.000151	CcSEcCtD
Alitretinoin—Hyperhidrosis—Hydrocortisone—atopic dermatitis	8.25e-05	0.000151	CcSEcCtD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	8.24e-05	0.00147	CbGpPWpGaD
Alitretinoin—Dry mouth—Triamcinolone—atopic dermatitis	8.2e-05	0.00015	CcSEcCtD
Alitretinoin—RXRA—Metabolism—ADSL—atopic dermatitis	8.16e-05	0.00145	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—IFNG—atopic dermatitis	8.16e-05	0.00145	CbGpPWpGaD
Alitretinoin—Anorexia—Hydrocortisone—atopic dermatitis	8.14e-05	0.000149	CcSEcCtD
Alitretinoin—Nausea—Tacrolimus—atopic dermatitis	8.13e-05	0.000149	CcSEcCtD
Alitretinoin—Angiopathy—Prednisone—atopic dermatitis	8.11e-05	0.000149	CcSEcCtD
Alitretinoin—Confusional state—Methylprednisolone—atopic dermatitis	8.09e-05	0.000148	CcSEcCtD
Alitretinoin—Malaise—Betamethasone—atopic dermatitis	8.06e-05	0.000148	CcSEcCtD
Alitretinoin—Malaise—Dexamethasone—atopic dermatitis	8.06e-05	0.000148	CcSEcCtD
Alitretinoin—Anaphylactic shock—Triamcinolone—atopic dermatitis	8.04e-05	0.000147	CcSEcCtD
Alitretinoin—Oedema—Triamcinolone—atopic dermatitis	8.04e-05	0.000147	CcSEcCtD
Alitretinoin—Anaphylactic shock—Methylprednisolone—atopic dermatitis	8.02e-05	0.000147	CcSEcCtD
Alitretinoin—Syncope—Dexamethasone—atopic dermatitis	8.01e-05	0.000147	CcSEcCtD
Alitretinoin—Syncope—Betamethasone—atopic dermatitis	8.01e-05	0.000147	CcSEcCtD
Alitretinoin—Arrhythmia—Prednisone—atopic dermatitis	7.99e-05	0.000146	CcSEcCtD
Alitretinoin—Infection—Triamcinolone—atopic dermatitis	7.99e-05	0.000146	CcSEcCtD
Alitretinoin—Hypotension—Hydrocortisone—atopic dermatitis	7.98e-05	0.000146	CcSEcCtD
Alitretinoin—Infection—Methylprednisolone—atopic dermatitis	7.97e-05	0.000146	CcSEcCtD
Alitretinoin—RARG—Gene Expression—PPARA—atopic dermatitis	7.93e-05	0.00141	CbGpPWpGaD
Alitretinoin—Shock—Triamcinolone—atopic dermatitis	7.91e-05	0.000145	CcSEcCtD
Alitretinoin—Insomnia—Prednisolone—atopic dermatitis	7.91e-05	0.000145	CcSEcCtD
Alitretinoin—Alopecia—Prednisone—atopic dermatitis	7.9e-05	0.000145	CcSEcCtD
Alitretinoin—Shock—Methylprednisolone—atopic dermatitis	7.89e-05	0.000144	CcSEcCtD
Alitretinoin—Nervous system disorder—Methylprednisolone—atopic dermatitis	7.87e-05	0.000144	CcSEcCtD
Alitretinoin—Loss of consciousness—Betamethasone—atopic dermatitis	7.86e-05	0.000144	CcSEcCtD
Alitretinoin—Loss of consciousness—Dexamethasone—atopic dermatitis	7.86e-05	0.000144	CcSEcCtD
Alitretinoin—Paraesthesia—Prednisolone—atopic dermatitis	7.85e-05	0.000144	CcSEcCtD
Alitretinoin—Tachycardia—Triamcinolone—atopic dermatitis	7.85e-05	0.000144	CcSEcCtD
Alitretinoin—Mental disorder—Prednisone—atopic dermatitis	7.83e-05	0.000143	CcSEcCtD
Alitretinoin—Tachycardia—Methylprednisolone—atopic dermatitis	7.83e-05	0.000143	CcSEcCtD
Alitretinoin—Skin disorder—Methylprednisolone—atopic dermatitis	7.79e-05	0.000143	CcSEcCtD
Alitretinoin—Malnutrition—Prednisone—atopic dermatitis	7.78e-05	0.000142	CcSEcCtD
Alitretinoin—Erythema—Prednisone—atopic dermatitis	7.78e-05	0.000142	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	7.78e-05	0.000142	CcSEcCtD
Alitretinoin—Hyperhidrosis—Triamcinolone—atopic dermatitis	7.77e-05	0.000142	CcSEcCtD
Alitretinoin—Hyperhidrosis—Methylprednisolone—atopic dermatitis	7.75e-05	0.000142	CcSEcCtD
Alitretinoin—Convulsion—Betamethasone—atopic dermatitis	7.74e-05	0.000142	CcSEcCtD
Alitretinoin—Convulsion—Dexamethasone—atopic dermatitis	7.74e-05	0.000142	CcSEcCtD
Alitretinoin—Insomnia—Hydrocortisone—atopic dermatitis	7.72e-05	0.000141	CcSEcCtD
Alitretinoin—Hypertension—Betamethasone—atopic dermatitis	7.72e-05	0.000141	CcSEcCtD
Alitretinoin—Hypertension—Dexamethasone—atopic dermatitis	7.72e-05	0.000141	CcSEcCtD
Alitretinoin—Paraesthesia—Hydrocortisone—atopic dermatitis	7.67e-05	0.00014	CcSEcCtD
Alitretinoin—Myalgia—Dexamethasone—atopic dermatitis	7.61e-05	0.000139	CcSEcCtD
Alitretinoin—Myalgia—Betamethasone—atopic dermatitis	7.61e-05	0.000139	CcSEcCtD
Alitretinoin—ABCB1—Allograft Rejection—CXCL8—atopic dermatitis	7.59e-05	0.00135	CbGpPWpGaD
Alitretinoin—Anxiety—Betamethasone—atopic dermatitis	7.58e-05	0.000139	CcSEcCtD
Alitretinoin—Anxiety—Dexamethasone—atopic dermatitis	7.58e-05	0.000139	CcSEcCtD
Alitretinoin—Discomfort—Betamethasone—atopic dermatitis	7.52e-05	0.000138	CcSEcCtD
Alitretinoin—Discomfort—Dexamethasone—atopic dermatitis	7.52e-05	0.000138	CcSEcCtD
Alitretinoin—Dyspepsia—Hydrocortisone—atopic dermatitis	7.51e-05	0.000138	CcSEcCtD
Alitretinoin—Hypotension—Methylprednisolone—atopic dermatitis	7.49e-05	0.000137	CcSEcCtD
Alitretinoin—Pain—Prednisolone—atopic dermatitis	7.48e-05	0.000137	CcSEcCtD
Alitretinoin—Decreased appetite—Hydrocortisone—atopic dermatitis	7.42e-05	0.000136	CcSEcCtD
Alitretinoin—RXRA—Generic Transcription Pathway—PPARA—atopic dermatitis	7.38e-05	0.00131	CbGpPWpGaD
Alitretinoin—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	7.37e-05	0.000135	CcSEcCtD
Alitretinoin—Fatigue—Hydrocortisone—atopic dermatitis	7.36e-05	0.000135	CcSEcCtD
Alitretinoin—Vision blurred—Prednisone—atopic dermatitis	7.34e-05	0.000134	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	7.32e-05	0.000134	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	7.31e-05	0.000134	CcSEcCtD
Alitretinoin—Pain—Hydrocortisone—atopic dermatitis	7.3e-05	0.000134	CcSEcCtD
Alitretinoin—Anaphylactic shock—Betamethasone—atopic dermatitis	7.29e-05	0.000134	CcSEcCtD
Alitretinoin—Anaphylactic shock—Dexamethasone—atopic dermatitis	7.29e-05	0.000134	CcSEcCtD
Alitretinoin—Oedema—Dexamethasone—atopic dermatitis	7.29e-05	0.000134	CcSEcCtD
Alitretinoin—Oedema—Betamethasone—atopic dermatitis	7.29e-05	0.000134	CcSEcCtD
Alitretinoin—ABCB1—Allograft Rejection—IL1B—atopic dermatitis	7.28e-05	0.0013	CbGpPWpGaD
Alitretinoin—Insomnia—Triamcinolone—atopic dermatitis	7.27e-05	0.000133	CcSEcCtD
Alitretinoin—Insomnia—Methylprednisolone—atopic dermatitis	7.25e-05	0.000133	CcSEcCtD
Alitretinoin—RXRG—Gene Expression—PPARA—atopic dermatitis	7.25e-05	0.00129	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—IL2—atopic dermatitis	7.25e-05	0.00129	CbGpPWpGaD
Alitretinoin—Infection—Betamethasone—atopic dermatitis	7.25e-05	0.000133	CcSEcCtD
Alitretinoin—Infection—Dexamethasone—atopic dermatitis	7.25e-05	0.000133	CcSEcCtD
Alitretinoin—Ill-defined disorder—Prednisone—atopic dermatitis	7.22e-05	0.000132	CcSEcCtD
Alitretinoin—Paraesthesia—Triamcinolone—atopic dermatitis	7.22e-05	0.000132	CcSEcCtD
Alitretinoin—Feeling abnormal—Prednisolone—atopic dermatitis	7.2e-05	0.000132	CcSEcCtD
Alitretinoin—Paraesthesia—Methylprednisolone—atopic dermatitis	7.2e-05	0.000132	CcSEcCtD
Alitretinoin—Anaemia—Prednisone—atopic dermatitis	7.19e-05	0.000132	CcSEcCtD
Alitretinoin—Shock—Betamethasone—atopic dermatitis	7.18e-05	0.000131	CcSEcCtD
Alitretinoin—Shock—Dexamethasone—atopic dermatitis	7.18e-05	0.000131	CcSEcCtD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—atopic dermatitis	7.17e-05	0.00128	CbGpPWpGaD
Alitretinoin—Dyspnoea—Triamcinolone—atopic dermatitis	7.17e-05	0.000131	CcSEcCtD
Alitretinoin—RXRA—Adipogenesis—IL6—atopic dermatitis	7.16e-05	0.00127	CbGpPWpGaD
Alitretinoin—Nervous system disorder—Dexamethasone—atopic dermatitis	7.15e-05	0.000131	CcSEcCtD
Alitretinoin—Nervous system disorder—Betamethasone—atopic dermatitis	7.15e-05	0.000131	CcSEcCtD
Alitretinoin—Agitation—Prednisone—atopic dermatitis	7.15e-05	0.000131	CcSEcCtD
Alitretinoin—Thrombocytopenia—Betamethasone—atopic dermatitis	7.14e-05	0.000131	CcSEcCtD
Alitretinoin—Thrombocytopenia—Dexamethasone—atopic dermatitis	7.14e-05	0.000131	CcSEcCtD
Alitretinoin—Tachycardia—Dexamethasone—atopic dermatitis	7.12e-05	0.00013	CcSEcCtD
Alitretinoin—Tachycardia—Betamethasone—atopic dermatitis	7.12e-05	0.00013	CcSEcCtD
Alitretinoin—RARB—Gene Expression—PPARA—atopic dermatitis	7.11e-05	0.00127	CbGpPWpGaD
Alitretinoin—Dyspepsia—Triamcinolone—atopic dermatitis	7.08e-05	0.00013	CcSEcCtD
Alitretinoin—Dyspepsia—Methylprednisolone—atopic dermatitis	7.06e-05	0.000129	CcSEcCtD
Alitretinoin—Hyperhidrosis—Dexamethasone—atopic dermatitis	7.05e-05	0.000129	CcSEcCtD
Alitretinoin—Hyperhidrosis—Betamethasone—atopic dermatitis	7.05e-05	0.000129	CcSEcCtD
Alitretinoin—Feeling abnormal—Hydrocortisone—atopic dermatitis	7.04e-05	0.000129	CcSEcCtD
Alitretinoin—Malaise—Prednisone—atopic dermatitis	7.02e-05	0.000128	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	6.98e-05	0.000128	CcSEcCtD
Alitretinoin—Syncope—Prednisone—atopic dermatitis	6.98e-05	0.000128	CcSEcCtD
Alitretinoin—Anorexia—Dexamethasone—atopic dermatitis	6.95e-05	0.000127	CcSEcCtD
Alitretinoin—Anorexia—Betamethasone—atopic dermatitis	6.95e-05	0.000127	CcSEcCtD
Alitretinoin—RXRA—Developmental Biology—PPARA—atopic dermatitis	6.95e-05	0.00124	CbGpPWpGaD
Alitretinoin—Urticaria—Prednisolone—atopic dermatitis	6.94e-05	0.000127	CcSEcCtD
Alitretinoin—Fatigue—Triamcinolone—atopic dermatitis	6.93e-05	0.000127	CcSEcCtD
Alitretinoin—Fatigue—Methylprednisolone—atopic dermatitis	6.92e-05	0.000127	CcSEcCtD
Alitretinoin—Pain—Triamcinolone—atopic dermatitis	6.87e-05	0.000126	CcSEcCtD
Alitretinoin—Loss of consciousness—Prednisone—atopic dermatitis	6.84e-05	0.000125	CcSEcCtD
Alitretinoin—RARA—Gene Expression—PPARA—atopic dermatitis	6.82e-05	0.00121	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—PPARA—atopic dermatitis	6.82e-05	0.00121	CbGpPWpGaD
Alitretinoin—Hypotension—Dexamethasone—atopic dermatitis	6.82e-05	0.000125	CcSEcCtD
Alitretinoin—Hypotension—Betamethasone—atopic dermatitis	6.82e-05	0.000125	CcSEcCtD
Alitretinoin—Urticaria—Hydrocortisone—atopic dermatitis	6.78e-05	0.000124	CcSEcCtD
Alitretinoin—Body temperature increased—Hydrocortisone—atopic dermatitis	6.75e-05	0.000124	CcSEcCtD
Alitretinoin—Abdominal pain—Hydrocortisone—atopic dermatitis	6.75e-05	0.000124	CcSEcCtD
Alitretinoin—Convulsion—Prednisone—atopic dermatitis	6.74e-05	0.000123	CcSEcCtD
Alitretinoin—Hypertension—Prednisone—atopic dermatitis	6.72e-05	0.000123	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	6.65e-05	0.000122	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	6.65e-05	0.000122	CcSEcCtD
Alitretinoin—Arthralgia—Prednisone—atopic dermatitis	6.63e-05	0.000121	CcSEcCtD
Alitretinoin—Myalgia—Prednisone—atopic dermatitis	6.63e-05	0.000121	CcSEcCtD
Alitretinoin—Feeling abnormal—Triamcinolone—atopic dermatitis	6.62e-05	0.000121	CcSEcCtD
Alitretinoin—Feeling abnormal—Methylprednisolone—atopic dermatitis	6.61e-05	0.000121	CcSEcCtD
Alitretinoin—Anxiety—Prednisone—atopic dermatitis	6.6e-05	0.000121	CcSEcCtD
Alitretinoin—Insomnia—Betamethasone—atopic dermatitis	6.6e-05	0.000121	CcSEcCtD
Alitretinoin—Insomnia—Dexamethasone—atopic dermatitis	6.6e-05	0.000121	CcSEcCtD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	6.58e-05	0.00012	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	6.56e-05	0.00012	CcSEcCtD
Alitretinoin—Paraesthesia—Betamethasone—atopic dermatitis	6.55e-05	0.00012	CcSEcCtD
Alitretinoin—Paraesthesia—Dexamethasone—atopic dermatitis	6.55e-05	0.00012	CcSEcCtD
Alitretinoin—Discomfort—Prednisone—atopic dermatitis	6.55e-05	0.00012	CcSEcCtD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	6.52e-05	0.00116	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—atopic dermatitis	6.5e-05	0.00116	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—atopic dermatitis	6.5e-05	0.00116	CbGpPWpGaD
Alitretinoin—Hypersensitivity—Prednisolone—atopic dermatitis	6.44e-05	0.000118	CcSEcCtD
Alitretinoin—Dyspepsia—Betamethasone—atopic dermatitis	6.42e-05	0.000118	CcSEcCtD
Alitretinoin—Dyspepsia—Dexamethasone—atopic dermatitis	6.42e-05	0.000118	CcSEcCtD
Alitretinoin—Urticaria—Triamcinolone—atopic dermatitis	6.39e-05	0.000117	CcSEcCtD
Alitretinoin—Urticaria—Methylprednisolone—atopic dermatitis	6.37e-05	0.000117	CcSEcCtD
Alitretinoin—Body temperature increased—Triamcinolone—atopic dermatitis	6.35e-05	0.000116	CcSEcCtD
Alitretinoin—Oedema—Prednisone—atopic dermatitis	6.35e-05	0.000116	CcSEcCtD
Alitretinoin—Anaphylactic shock—Prednisone—atopic dermatitis	6.35e-05	0.000116	CcSEcCtD
Alitretinoin—Abdominal pain—Methylprednisolone—atopic dermatitis	6.34e-05	0.000116	CcSEcCtD
Alitretinoin—Decreased appetite—Dexamethasone—atopic dermatitis	6.34e-05	0.000116	CcSEcCtD
Alitretinoin—Decreased appetite—Betamethasone—atopic dermatitis	6.34e-05	0.000116	CcSEcCtD
Alitretinoin—Infection—Prednisone—atopic dermatitis	6.31e-05	0.000116	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	6.3e-05	0.000115	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Betamethasone—atopic dermatitis	6.3e-05	0.000115	CcSEcCtD
Alitretinoin—Hypersensitivity—Hydrocortisone—atopic dermatitis	6.29e-05	0.000115	CcSEcCtD
Alitretinoin—Fatigue—Dexamethasone—atopic dermatitis	6.29e-05	0.000115	CcSEcCtD
Alitretinoin—Fatigue—Betamethasone—atopic dermatitis	6.29e-05	0.000115	CcSEcCtD
Alitretinoin—Shock—Prednisone—atopic dermatitis	6.25e-05	0.000114	CcSEcCtD
Alitretinoin—Pain—Betamethasone—atopic dermatitis	6.24e-05	0.000114	CcSEcCtD
Alitretinoin—Pain—Dexamethasone—atopic dermatitis	6.24e-05	0.000114	CcSEcCtD
Alitretinoin—Nervous system disorder—Prednisone—atopic dermatitis	6.23e-05	0.000114	CcSEcCtD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	6.2e-05	0.0011	CbGpPWpGaD
Alitretinoin—Tachycardia—Prednisone—atopic dermatitis	6.2e-05	0.000113	CcSEcCtD
Alitretinoin—Skin disorder—Prednisone—atopic dermatitis	6.17e-05	0.000113	CcSEcCtD
Alitretinoin—Hyperhidrosis—Prednisone—atopic dermatitis	6.14e-05	0.000112	CcSEcCtD
Alitretinoin—Asthenia—Hydrocortisone—atopic dermatitis	6.13e-05	0.000112	CcSEcCtD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	6.1e-05	0.00109	CbGpPWpGaD
Alitretinoin—Anorexia—Prednisone—atopic dermatitis	6.05e-05	0.000111	CcSEcCtD
Alitretinoin—Pruritus—Hydrocortisone—atopic dermatitis	6.04e-05	0.000111	CcSEcCtD
Alitretinoin—Feeling abnormal—Betamethasone—atopic dermatitis	6.01e-05	0.00011	CcSEcCtD
Alitretinoin—Feeling abnormal—Dexamethasone—atopic dermatitis	6.01e-05	0.00011	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Dexamethasone—atopic dermatitis	5.96e-05	0.000109	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Betamethasone—atopic dermatitis	5.96e-05	0.000109	CcSEcCtD
Alitretinoin—Hypersensitivity—Triamcinolone—atopic dermatitis	5.92e-05	0.000108	CcSEcCtD
Alitretinoin—Hypersensitivity—Methylprednisolone—atopic dermatitis	5.91e-05	0.000108	CcSEcCtD
Alitretinoin—RXRA—Transmembrane transport of small molecules—PPARA—atopic dermatitis	5.9e-05	0.00105	CbGpPWpGaD
Alitretinoin—Diarrhoea—Hydrocortisone—atopic dermatitis	5.84e-05	0.000107	CcSEcCtD
Alitretinoin—Urticaria—Betamethasone—atopic dermatitis	5.79e-05	0.000106	CcSEcCtD
Alitretinoin—Urticaria—Dexamethasone—atopic dermatitis	5.79e-05	0.000106	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Prednisone—atopic dermatitis	5.79e-05	0.000106	CcSEcCtD
Alitretinoin—Dizziness—Prednisolone—atopic dermatitis	5.78e-05	0.000106	CcSEcCtD
Alitretinoin—Asthenia—Triamcinolone—atopic dermatitis	5.77e-05	0.000106	CcSEcCtD
Alitretinoin—Body temperature increased—Dexamethasone—atopic dermatitis	5.77e-05	0.000106	CcSEcCtD
Alitretinoin—Abdominal pain—Dexamethasone—atopic dermatitis	5.77e-05	0.000106	CcSEcCtD
Alitretinoin—Body temperature increased—Betamethasone—atopic dermatitis	5.77e-05	0.000106	CcSEcCtD
Alitretinoin—Abdominal pain—Betamethasone—atopic dermatitis	5.77e-05	0.000106	CcSEcCtD
Alitretinoin—Asthenia—Methylprednisolone—atopic dermatitis	5.75e-05	0.000105	CcSEcCtD
Alitretinoin—Insomnia—Prednisone—atopic dermatitis	5.75e-05	0.000105	CcSEcCtD
Alitretinoin—Paraesthesia—Prednisone—atopic dermatitis	5.7e-05	0.000104	CcSEcCtD
Alitretinoin—Pruritus—Triamcinolone—atopic dermatitis	5.69e-05	0.000104	CcSEcCtD
Alitretinoin—Pruritus—Methylprednisolone—atopic dermatitis	5.67e-05	0.000104	CcSEcCtD
Alitretinoin—Dizziness—Hydrocortisone—atopic dermatitis	5.65e-05	0.000103	CcSEcCtD
Alitretinoin—Dyspepsia—Prednisone—atopic dermatitis	5.59e-05	0.000102	CcSEcCtD
Alitretinoin—Decreased appetite—Prednisone—atopic dermatitis	5.52e-05	0.000101	CcSEcCtD
Alitretinoin—Rash—Prednisolone—atopic dermatitis	5.51e-05	0.000101	CcSEcCtD
Alitretinoin—Dermatitis—Prednisolone—atopic dermatitis	5.51e-05	0.000101	CcSEcCtD
Alitretinoin—Diarrhoea—Methylprednisolone—atopic dermatitis	5.49e-05	0.0001	CcSEcCtD
Alitretinoin—Fatigue—Prednisone—atopic dermatitis	5.48e-05	0.0001	CcSEcCtD
Alitretinoin—Headache—Prednisolone—atopic dermatitis	5.48e-05	0.0001	CcSEcCtD
Alitretinoin—Constipation—Prednisone—atopic dermatitis	5.43e-05	9.94e-05	CcSEcCtD
Alitretinoin—Vomiting—Hydrocortisone—atopic dermatitis	5.43e-05	9.94e-05	CcSEcCtD
Alitretinoin—Rash—Hydrocortisone—atopic dermatitis	5.38e-05	9.85e-05	CcSEcCtD
Alitretinoin—Dermatitis—Hydrocortisone—atopic dermatitis	5.38e-05	9.85e-05	CcSEcCtD
Alitretinoin—Headache—Hydrocortisone—atopic dermatitis	5.35e-05	9.79e-05	CcSEcCtD
Alitretinoin—Dizziness—Triamcinolone—atopic dermatitis	5.32e-05	9.73e-05	CcSEcCtD
Alitretinoin—Dizziness—Methylprednisolone—atopic dermatitis	5.3e-05	9.71e-05	CcSEcCtD
Alitretinoin—ABCB1—Allograft Rejection—TNF—atopic dermatitis	5.28e-05	0.00094	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	5.25e-05	0.000934	CbGpPWpGaD
Alitretinoin—Feeling abnormal—Prednisone—atopic dermatitis	5.23e-05	9.58e-05	CcSEcCtD
Alitretinoin—Asthenia—Dexamethasone—atopic dermatitis	5.23e-05	9.58e-05	CcSEcCtD
Alitretinoin—Asthenia—Betamethasone—atopic dermatitis	5.23e-05	9.58e-05	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Prednisone—atopic dermatitis	5.19e-05	9.51e-05	CcSEcCtD
Alitretinoin—Nausea—Prednisolone—atopic dermatitis	5.19e-05	9.51e-05	CcSEcCtD
Alitretinoin—Pruritus—Dexamethasone—atopic dermatitis	5.16e-05	9.45e-05	CcSEcCtD
Alitretinoin—Pruritus—Betamethasone—atopic dermatitis	5.16e-05	9.45e-05	CcSEcCtD
Alitretinoin—Vomiting—Triamcinolone—atopic dermatitis	5.11e-05	9.36e-05	CcSEcCtD
Alitretinoin—Vomiting—Methylprednisolone—atopic dermatitis	5.1e-05	9.34e-05	CcSEcCtD
Alitretinoin—Nausea—Hydrocortisone—atopic dermatitis	5.07e-05	9.28e-05	CcSEcCtD
Alitretinoin—Rash—Triamcinolone—atopic dermatitis	5.07e-05	9.28e-05	CcSEcCtD
Alitretinoin—Dermatitis—Triamcinolone—atopic dermatitis	5.06e-05	9.27e-05	CcSEcCtD
Alitretinoin—Rash—Methylprednisolone—atopic dermatitis	5.06e-05	9.26e-05	CcSEcCtD
Alitretinoin—Dermatitis—Methylprednisolone—atopic dermatitis	5.05e-05	9.25e-05	CcSEcCtD
Alitretinoin—Urticaria—Prednisone—atopic dermatitis	5.05e-05	9.24e-05	CcSEcCtD
Alitretinoin—Headache—Triamcinolone—atopic dermatitis	5.04e-05	9.22e-05	CcSEcCtD
Alitretinoin—Headache—Methylprednisolone—atopic dermatitis	5.02e-05	9.2e-05	CcSEcCtD
Alitretinoin—Body temperature increased—Prednisone—atopic dermatitis	5.02e-05	9.19e-05	CcSEcCtD
Alitretinoin—Abdominal pain—Prednisone—atopic dermatitis	5.02e-05	9.19e-05	CcSEcCtD
Alitretinoin—Diarrhoea—Dexamethasone—atopic dermatitis	4.99e-05	9.14e-05	CcSEcCtD
Alitretinoin—Diarrhoea—Betamethasone—atopic dermatitis	4.99e-05	9.14e-05	CcSEcCtD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	4.87e-05	0.000866	CbGpPWpGaD
Alitretinoin—Dizziness—Betamethasone—atopic dermatitis	4.82e-05	8.83e-05	CcSEcCtD
Alitretinoin—Dizziness—Dexamethasone—atopic dermatitis	4.82e-05	8.83e-05	CcSEcCtD
Alitretinoin—Nausea—Triamcinolone—atopic dermatitis	4.77e-05	8.74e-05	CcSEcCtD
Alitretinoin—Nausea—Methylprednisolone—atopic dermatitis	4.76e-05	8.72e-05	CcSEcCtD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	4.74e-05	0.000843	CbGpPWpGaD
Alitretinoin—Hypersensitivity—Prednisone—atopic dermatitis	4.68e-05	8.57e-05	CcSEcCtD
Alitretinoin—Vomiting—Betamethasone—atopic dermatitis	4.64e-05	8.49e-05	CcSEcCtD
Alitretinoin—Vomiting—Dexamethasone—atopic dermatitis	4.64e-05	8.49e-05	CcSEcCtD
Alitretinoin—Rash—Dexamethasone—atopic dermatitis	4.6e-05	8.42e-05	CcSEcCtD
Alitretinoin—Rash—Betamethasone—atopic dermatitis	4.6e-05	8.42e-05	CcSEcCtD
Alitretinoin—Dermatitis—Dexamethasone—atopic dermatitis	4.59e-05	8.41e-05	CcSEcCtD
Alitretinoin—Dermatitis—Betamethasone—atopic dermatitis	4.59e-05	8.41e-05	CcSEcCtD
Alitretinoin—Headache—Dexamethasone—atopic dermatitis	4.57e-05	8.37e-05	CcSEcCtD
Alitretinoin—Headache—Betamethasone—atopic dermatitis	4.57e-05	8.37e-05	CcSEcCtD
Alitretinoin—Asthenia—Prednisone—atopic dermatitis	4.56e-05	8.34e-05	CcSEcCtD
Alitretinoin—Pruritus—Prednisone—atopic dermatitis	4.49e-05	8.23e-05	CcSEcCtD
Alitretinoin—Diarrhoea—Prednisone—atopic dermatitis	4.35e-05	7.96e-05	CcSEcCtD
Alitretinoin—Nausea—Betamethasone—atopic dermatitis	4.33e-05	7.93e-05	CcSEcCtD
Alitretinoin—Nausea—Dexamethasone—atopic dermatitis	4.33e-05	7.93e-05	CcSEcCtD
Alitretinoin—Dizziness—Prednisone—atopic dermatitis	4.2e-05	7.69e-05	CcSEcCtD
Alitretinoin—Vomiting—Prednisone—atopic dermatitis	4.04e-05	7.39e-05	CcSEcCtD
Alitretinoin—Rash—Prednisone—atopic dermatitis	4.01e-05	7.33e-05	CcSEcCtD
Alitretinoin—Dermatitis—Prednisone—atopic dermatitis	4e-05	7.33e-05	CcSEcCtD
Alitretinoin—Headache—Prednisone—atopic dermatitis	3.98e-05	7.29e-05	CcSEcCtD
Alitretinoin—Nausea—Prednisone—atopic dermatitis	3.77e-05	6.91e-05	CcSEcCtD
Alitretinoin—RXRA—Gene Expression—PPARA—atopic dermatitis	3.55e-05	0.000632	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GLB1—atopic dermatitis	3.4e-05	0.000605	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	3.29e-05	0.000586	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ADSL—atopic dermatitis	3.26e-05	0.00058	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—TNF—atopic dermatitis	3.05e-05	0.000543	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PPARA—atopic dermatitis	2.76e-05	0.000492	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GLB1—atopic dermatitis	2.72e-05	0.000483	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	2.61e-05	0.000464	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ADSL—atopic dermatitis	2.6e-05	0.000463	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—IL6—atopic dermatitis	2.46e-05	0.000438	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	2.36e-05	0.000419	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	1.98e-05	0.000352	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PPARA—atopic dermatitis	1.1e-05	0.000196	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PPARA—atopic dermatitis	8.82e-06	0.000157	CbGpPWpGaD
